Literature DB >> 1693164

Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.

W Fuchs1, H J Rziha, N Lukàcs, I Braunschweiger, N Visser, D Lütticken, C S Schreurs, H J Thiel, T C Mettenleiter.   

Abstract

Overlapping fragments of the gene encoding glycoprotein gI of pseudorabies virus (PRV; herpesvirus suis 1) were expressed in bacteria. Using the fusion proteins and a panel of monoclonal antibodies (MAbs) against gI as well as swine sera we found that the N-terminal part of gI (residues 33 to approximately 100) contains a highly antigenic and immunogenic domain. Transfer of antibodies binding to this region as well as vaccination with fusion proteins containing the N terminus of gI are able to confer protection to mice against a lethal challenge of virus. The results show that gI, which is non-essential for virus replication in tissue culture, can induce neutralizing and protective antibodies. The potential suitability of fusion proteins encompassing N-terminal parts of gI as diagnostic tools is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693164     DOI: 10.1099/0022-1317-71-5-1141

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

Authors:  B T Ober; B Teufel; K H Wiesmüller; G Jung; E Pfaff; A Saalmüller; H J Rziha
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Role of envelope protein gE endocytosis in the pseudorabies virus life cycle.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  Suppression of the interferon-mediated innate immune response by pseudorabies virus.

Authors:  Alla Brukman; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 5.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.

Authors:  L Jacobs; H J Rziha; T G Kimman; A L Gielkens; J T Van Oirschot
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins.

Authors:  M E Whealy; J P Card; A K Robbins; J R Dubin; H J Rziha; L W Enquist
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.

Authors:  S Heffner; F Kovács; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.

Authors:  R Sinclair; M M Binns; E D Chirnside; J A Mumford
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.